The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Pfizer (Inst)
Palbociclib (PAL) in combination with fulvestrant (F) in pre-/peri-menopausal (PreM) women with metastatic breast cancer (MBC) and prior progression on endocrine therapy – results from Paloma-3.
 
Sibylle Loibl
Honoraria - Novartis; Roche Pharma AG
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); PharmaSea (Inst); Roche Pharma AG (Inst)
 
Nicholas C. Turner
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
 
Jungsil Ro
No Relationships to Disclose
 
Massimo Cristofanilli
No Relationships to Disclose
 
Hiroji Iwata
Research Funding - AstraZeneca; Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Lilly; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Eisai
 
Seock-Ah Im
Consulting or Advisory Role - AstraZeneca; Novartis; Roche
Research Funding - AstraZeneca
 
Norikazu Masuda
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Kyowa Hakko Kirin
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Kyowa Hakko Kirin (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma; Eisai; Kyowa Hakko Kirin
 
Sherene Loi
Research Funding - Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - PI3K pathway gene signature granted by the European and US patent offices
 
Fabrice Andre
Research Funding - AstraZeneca (Inst); Eisai (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Novartis; Roche
 
Nadia Harbeck
Honoraria - Amgen; Celgene; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Genomic Health; Novartis; Roche/Genentech; Sandoz; Wilex
Research Funding - Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Sunil Verma
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; MERCK; Novartis; Pfizer; Roche
 
Elizabeth Folkerd
No Relationships to Disclose
 
Kathy Puyana Theall
Employment - Pfizer
 
Ke Zhang
Employment - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Cynthia Huang Bartlett
Employment - Pfizer
 
Mitch Dowsett
No Relationships to Disclose